ArticleFrontiers in neuroscience2025
Brain functional network abnormalities in Parkinson's disease patients at different disease stages.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parkinson's disease (PD) is a neurodegenerative disorder with some progressive impairment and an unclear pathogenesis. Purpose: This study aimed to use resting-state functional magnetic resonance imaging (rs-fMRI) and graph analysis approaches to compare changes in brain functional network topology in PD at different disease stages. Materials and methods: A total of 58 PD patients, comprising 29 early-stage PD (PD-E) and 29 middle-to-late stage PD (PD-M), and 29 age- and sex-matched healthy control (HC) participants, were recruited. All subjects underwent clinical assessments and magnetic resonance imaging (MRI) scanning. We analyzed alterations in the global, regional, and modular topological characteristics of brain functional networks among different disease stages of PD patients and HC participants. Furthermore, we also examined the relationship between topological features with significant group effects and clinical characteristics, including the Movement Disorder Society's Unified Parkinson's Disease Rating Scale III (MDS-UPDRS III) score and Hoehn and Yahr (H&Y) stage. Results: At the global level, PD-M and PD-E exhibited lower clustering coefficient, and PD-M also exhibited lower local efficiency and normalized characteristic path length relative to HC. At the regional level, PD-M and PD-E showed lower nodal centrality in temporal-occipital regions and higher centrality in brain regions related to the default mode network and the frontoparietal control network compared to HC. Notably, nodal centrality metrics of the left middle frontal gyrus and the temporal pole of the right middle temporal gyrus were associated with the MDS-UPDRS III score and H&Y stage. Conclusion: This study found that the brain functional networks were disrupted at varying degrees in patients with PD at different disease stages. These findings contribute to our understanding of the topological changes in the neural networks associated with the severity of PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.